[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"respiratory-rate\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:respiratory-rate":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,49,77,102],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":30,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":48},"100538550","the-pars-study-paediatric-advanced-respiratory-service-study---an-observational-diagnostic-feasibility-study-100538550",false,"NCT06292299","The PARS Study: Paediatric Advanced Respiratory Service Study - An Observational Diagnostic Feasibility Study","PARS","Inclusion Criteria:\n\nGroup 1 - CR-poly group\n\n* Patient undergoing overnight CR-poly\n* Age birth to \\>=16 years\n* Are willing and able to give informed assent\u002Fconsent or have available next of Kin to provide informed consent on the participant\\'s behalf\n* Able (in the Investigators opinion) to comply with all study requirements\n* Can speak and read English\n\nGroup 2 - Apnoea group\n\n* Inpatient in neonatal unit\n* Age birth (from 30 weeks gestational age) to term corrected\n* Parents willing and able to give informed consent\n* Able (in the Investigators opinion) to comply with all study requirements\n* Can speak and read English\n\nGroup 3- VT Group attending epilepsy monitoirng unit\n\n* Inpatient receiving video-telemetry epilepsy monitoring unit\n* Age birth to \\\u003C16 years\n* Parents willing and able to give informed consent\n* Able (in the Investigators opinion) and willing to comply with all study requirements\n* Can speak and read English\n\nExclusion Criteria:\n\nGroup 1 - CR-poly group\n\n* Unable to provide consent and no next of kin to provide consent on participants behalf\n* Treating clinician deems patient inappropriate to be included in study\n\nGroup 2 - Apnoea group\n\n* No next of kin to provide consent on participants behalf\n* Treating clinician deems patient inappropriate to be included in study\n\nGroup 3- VT Group attending epilepsy monitoirng unit\n\n* Unable to provide consent and no next of kin to provide consent on participants behalf\n* Treating clinician deems patient inappropriate to be included in study","ALL","1 Minute","16 Years",{"count":20,"type":21},225,"ESTIMATED","7 Days","OBSERVATIONAL","Diagnostic investigations in paediatric respiratory and sleep medicine are often challenging due to patient size (due to prematurity), tolerability, and compliance with \"gold standard equipment\". Children with sensory\u002Fbehavioural issues, at increased risk of sleep disordered breathing (SDB), often find tolerating standard diagnostic equipment difficult. There is a need to develop non-invasive, wireless, devices designed for the paediatric population. Devices must address health in-equalities as high-risk children, with low birth weights, genetic syndromes, or complex neuro-disabilities, are often unable to undergo current investigations, particularly in sleep medicine. Prompt and accurate diagnosis of SDB is important to facilitate early intervention and improve outcomes\n\nInfants in the neonatal period can have immature breathing control which manifests as excessive central breathing pauses, apnoea's, whilst asleep requiring oxygen therapy. There is also a risk to newborn term infants of sudden unexpected neonatal collapse, even in \"low risk\" babies. Diagnosis of breathing issues in babies can be challenging since babies are often too small for standard monitoring equipment. Effective monitoring and appropriate treatment of apnoea's has been shown to improve prognosis in terms of 5-year mortality and neurodevelopmental outcomes.\n\nChildren with epilepsy are at risk of epileptic apnoea during a seizure (ictal) or post-ictal apnoea following an epileptic seizure. Epileptic and post-ictal apnoea have been implicated as causes of sudden unexpected death in epilepsy (SUDEP). Epilepsy affects approx. 50 million people worldwide. The risk of SUDEP varies in different underlying causes of epilepsy but is estimated to be the cause of 1.2 deaths for every 1,000 children with epilepsy each year.\n\nThis observational study is part of a phased clinical program of research that aims to validate a small wearable biosensor developed by PneumoWave Ltd in a paediatric clinical setting with the overall primary endpoints of monitoring and assessing respiratory pattern as an aid to sleep diagnostics, and as a device to monitor apnoea in neonatal patients and children with epilepsy at risk of SUDEP.",[26,27,28,29],"Sleep Disordered Breathing","Apnea of Prematurity","Respiratory Rate","Sudden Unexpected Death in Epilepsy",[26,31,32,33,28,34,35],"Neonatal Apnoea","Sleep Diagnostics","Wearable Device","Respiratory Pattern","Epilepsy","RECRUITING","2026-04-13",{"date":39,"type":40},"2026-04-14","ACTUAL",{"date":42,"type":40},"2024-03-01",{"date":44,"type":21},"2027-12",{"name":46,"class":47},"NHS Greater Clyde and Glasgow","OTHER",2,{"id":50,"slug":51,"hasResults":11,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":4,"eligibilityCriteria":55,"healthyVolunteers":11,"sex":16,"minAge":56,"maxAge":4,"enrollmentInfo":57,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":59,"conditions":60,"keywords":62,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":76},"100616004","accuracy-of-the-welch-allyn-connexspot-monitor-in-measuring-respiratory-rate-in-the-emergency-department-100616004","NCT07299968","Accuracy of the Welch Allyn ConnexSpot Monitor in Measuring Respiratory Rate in the Emergency Department","Evaluation of the Welch Allyn Connex Spot Monitor in Measuring Respiratory Rate in the Emergency Department: a Prospective Observational Study Protocol","Inclusion Criteria:\n\n\\- all patients aged ≥18 years.\n\nExclusion Criteria:\n\n* patients receiving invasive or non-invasive respiratory support;\n* patients with disorders causing involuntary movements;\n* skin or digit abnormalities preventing proper application of the pulse oximeter;\n* clinically unstable patients on arrival (requiring immediate transfer to the resuscitation area);\n* patients with a left ventricular assist device (LVAD).","18 Years",{"count":58,"type":21},170,"This prospective observational study will evaluate the accuracy of the Welch Allyn Connex Spot Monitor equipped with a Masimo SpO₂ finger sensor in measuring respiratory rate in the emergency department. Respiratory rate is a key predictor of patient deterioration, yet it is frequently measured inaccurately when assessed manually. In this study, respiratory rate values obtained by the monitor will be compared against manual counts performed by trained observers (physicians). An additional analysis will compare respiratory rates measured by trained observers with those recorded by triage nurses during triage. A subgroup analysis will also investigate whether cardiac arrhythmias influence measurement accuracy.\n\nThe aim is to examine if respiratory rates measured by the Welch Allyn Connex Spot Monitor are comparable to those obtained by trained observers and triage nurses in the emergency department.",[28,61],"Breathing Rate",[63,64,65],"respiratory rate","emergency department","Welch","NOT_YET_RECRUITING","2025-12-10",{"date":69,"type":40},"2025-12-23",{"date":71,"type":21},"2025-12",{"date":73,"type":21},"2026-02",{"name":75,"class":47},"Dr. Rapszky Gabriella Anna",1,{"id":78,"slug":79,"hasResults":11,"nctId":80,"briefTitle":81,"officialTitle":81,"acronym":82,"eligibilityCriteria":83,"healthyVolunteers":11,"sex":16,"minAge":56,"maxAge":4,"enrollmentInfo":84,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":86,"conditions":87,"keywords":4,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":76},"100440972","remote-investigation-and-assessment-of-vital-signs-100440972","NCT05022264","Remote Investigation and Assessment of Vital Signs","RIA-VS","Inclusion Criteria:\n\nThe same subject can't be enrolled more than once with the exception that subjects in WP1 may also be recruited to WP2.\n\nWP1+WP2:\n\n1. The patient is attending primary or secondary health care.\n2. The subject has provided informed consent.\n3. Age ≥18 years.\n4. Fluent in Swedish, English, Somali or Arabic (we will translate the patient information and ensure an interpreter can be present for translating questions).\n5. The patient is willing and able to give informed consent \".\n6. The investigator determines that the new study device, and the reference methods, can be used as intended with adequate safety.\n7. The delay in the management of each patient introduced by this study is approximately 15-20 minutes. Patients deemed being in such a severe medical condition that 15-20 minutes of delay is deemed detrimental will not be included.\n\nWP3:\n\n1. Patients attending primary health care.\n2. The subject has provided informed consent.\n3. Age ≥18 years.\n4. Fluent in Swedish, English, Somali or Arabic (we will translate the patient information and ensure an interpreter can be present for translating questions).\n5. The patient is willing and able to give informed consent .\n6. The investigator determines that the new study device, and the reference methods, can be used as intended with adequate safety.\n7. The delay in the management of each patient introduced by this study is approximately 15-20 minutes. Patients deemed being in such a severe medical condition that 15-20 minutes of delay is deemed detrimental will not be included.\n\nExclusion Criteria:\n\nSubjects are free to withdraw from the study at any point. Subjects will also be withdrawn from the study in case of unexpected depressed level of consciousness from inclusion up until all investigations are completed (during approximately 15-20 minutes). Any reduction in consciousness will incur that the subject is withdrawn.",{"count":85,"type":21},860,"The vital signs (pulse, systolic and diastolic blood pressure, respiratory rate, oxygen saturation and body temperature) are critical in assessing the severity and prognosis of infections. The devices used today for measuring the vital signs have to be in physical contact with the patients. There is an apparent risk of transferring infections from one patient to the next (or to healthcare professionals). Accurately obtaining vital signs is also important when managing other categories of patients where it may be relevant to obtain some of the vital signs such as pulse and blood pressure.\n\nThis project aims to evaluate a new camera-based system for contactless measurement of vital signs.",[88,89,28,90,91],"Blood Pressure","Pulse Rate","Oxygen Saturation","Body Temperature","2025-09-16",{"date":94,"type":40},"2025-09-22",{"date":96,"type":40},"2022-03-01",{"date":98,"type":21},"2027-06-30",{"name":100,"class":101},"Vastra Gotaland Region","OTHER_GOV",{"id":103,"slug":104,"hasResults":11,"nctId":105,"briefTitle":106,"officialTitle":107,"acronym":108,"eligibilityCriteria":109,"healthyVolunteers":11,"sex":16,"minAge":110,"maxAge":56,"enrollmentInfo":111,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":113,"conditions":114,"keywords":119,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":133,"lastUpdatePostDateStruct":134,"startDateStruct":136,"completionDateStruct":138,"leadSponsor":140,"locationsCount":76},"100473975","validation-of-vital-signs-recording-with-vt-patch-connected-devices-in-children-100473975","NCT05451875","Validation of Vital Signs Recording With VT-Patch Connected Devices in Children","Validation of Vital Signs Recording With VT-Patch® Connected Devices in Children","VT","Inclusion Criteria:\n\n* PICU monitoring for the next 24 hours\n\nExclusion Criteria:\n\n* Recent cardiac or thoracic surgery\n* Thoracic skin lesion that contraindicates the VT patch\n* No parental consent\n* Intermittent presence of one study observer in the patient room considered inappropriate by the physician or the nurse in charge because of the child's medical condition","1 Day",{"count":112,"type":21},48,": Patient readmission to PICU is a major point of concern for physicians because, although being a rare event, it has been strongly associated with more morbidity and death. Patient monitoring once they have left the PICU is drastically modified, and small connected devices could be an option to early identify patients at risk of PICU readmission. Such devices have been manufactured for the recording of vital signs in adults, but they do not exist for children.\n\nBesides, studies have recently shown that devices that use optical sensors may be less accurate in individuals with dark skin pigmentation since dark skin tones impose a limitation on optical biometric sensing. The wearable and medical device industry has not sufficiently addressed this issue yet. This is one of the main challenges that need to be addressed in this area to make sure the connected devices using this technology will work with all different skin colours including very dark skin.",[115,90,116,117,118,28],"Vital Signs","Children","Intensive Care Unit","Heart Rate",[120,121,122,123,124,125,126,127,128,116,129,130,131,132],"Vital signs","SPO2","ECG","Continuous","Skin temperature","Heart rate","VitalTracer","Wearable","All-in-one","PICU","Different Skin Color","Dark skin color","Monk Scale","2025-03-05",{"date":135,"type":40},"2025-03-10",{"date":137,"type":40},"2025-02-03",{"date":139,"type":21},"2025-12-31",{"name":141,"class":142},"VitalTracer Ltd.","INDUSTRY"]